News

This certification reflects the company's progress in climate and water efficiency, with outstanding performance in energy efficiency, emission reduction, and environmental policies.The company ...
A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, ...
EDT COPT Defense Properties (CDP) files automatic mixed securities shelfStay Ahead of the Market: Discover outperforming stocks and ...
Market Set for Explosive Growth, Projected to Reach $25.34 Billion by 2030 MIDDLETON, Mass., April 8, 2025 /PRNewswire/ -- QKS Group, a premier market intelligence ...
QKS Group, a premier market intelligence and advisory firm, has unveiled its latest comprehensive analysis of the global ...